Moderna: grant for influenza vaccine

(CercleFinance.com) - Moderna announces the award of a $176m public grant from the Biomedical Advanced Research and Development Authority (BARDA), to accelerate the development of mRNA-based pandemic influenza vaccines.


The project grant will support the advanced development of a pre-pandemic vaccine against the H5 influenza virus, but also includes additional options to prepare and accelerate a response to future public health threats.

In 2023, Moderna launched a Phase 1/2 study for an investigational pandemic influenza vaccine (mRNA-1018) in healthy adults, which includes vaccine candidates against H5 and H7 avian influenza viruses.


Copyright (c) 2024 CercleFinance.com. All rights reserved.